We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Glass Microbubbles Separate CD4+ T Cells by Buoyancy

By LabMedica International staff writers
Posted on 01 Feb 2015
Print article
Image: Glass microbubbles labeled with phycoerythrin-conjugated biotin (A). Schematic of buoyancy activated cell sorting (BACS). Surface-functionalized glass microbubbles bind to target cells after a brief rotary mixing (1-3). Cells attached by glass microbubbles float and are separated spontaneously by buoyancy (4) (B) (Photo courtesy of Technology).
Image: Glass microbubbles labeled with phycoerythrin-conjugated biotin (A). Schematic of buoyancy activated cell sorting (BACS). Surface-functionalized glass microbubbles bind to target cells after a brief rotary mixing (1-3). Cells attached by glass microbubbles float and are separated spontaneously by buoyancy (4) (B) (Photo courtesy of Technology).
For human immunodeficiency virus (HIV) infected patients the number of CD4+ T lymphocytes in peripheral blood is an important marker for monitoring disease progression of acquired immune deficiency syndrome (AIDS) and treatment efficacy.

The standard methods for enumerating cluster of differentiation 4+ (CD4+) T cells or mature T helper cells, by using fluorescence-activated cell sorting (FACS) or magnetic-activated cell sorting (MACS) are expensive and not easily accessible in remote or resource limited areas.

Scientists at the National Health Research Institutes (Zhunan Town, Taiwan) working with colleagues in the USA developed a method for a fast isolation strategy for CD4+ cells that involves mixing blood and glass microbubbles. After the specific binding of target cells to the microbubbles carrying specific antibodies on their surface, target cells will spontaneously float to the top of the blood vial and can be quickly separated. The use of this strategy demonstrated that the isolation of CD4+ cells in less than five minutes and with better than 90% efficiency. This strategy for cell isolation based on buoyancy and glass microbubbles is quick and inexpensive, minimizes blood handling, does not require magnetic fields, or centrifugation equipment, and could lead to new, efficient strategies for AIDS diagnosis in resource-limited areas.

One critical advantage of glass microbubbles is their reduced cost. These glass microbubbles have been mass-produced for use in many industrial applications including insulation, construction, paints, and transportation. The surface of the glass microbubbles can also be modified for attaching a variety of biochemicals to, using readily available protocols developed for glass substrate. In addition the buoyancy of the glass microbubbles allows for the capturing and separation of target cells from the unwanted cells by a simple "flip tube" motion. Together these features make the technology very attractive to the development of low-cost point-of-care devices for HIV monitoring. The study was published on December 26, 2014, in the journal Technology.

Related Links:
Taiwanese National Health Research Institutes


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more